image_pdfimage_print

Naiara Braghiroli, M.D.

April 25, 2023 – The Miami Cancer Institute Inaugural Skin Cancer Conference will be posted on Thursday, May 18th from 5:30 – 8:45 PM EST at Hilton Miami Dadeland. The objective of this symposium is to highlight the significant multidisciplinary approach to surveillance and personalized treatment for skin cancer. This conference, led by Naiara Braghiroli, M.D. will combine a series of fascinating lectures on the use of surgery, medicine, radiation therapy, and artificial intelligence to manage melanoma and non-melanoma skin cancers.

“This is an exciting opportunity to gather some of South Florida’s most prominent leaders in the skin cancer field. We look forward to continue educating our community on the best ways to care and treat skin cancer, with some of our newest treatment modalities and research”, shared Naiara Braghiroli, M.D., chief of skin cancer clinic at Miami Cancer Institute, part of Baptist Health.

The conference includes presentations from Miami Cancer Institute skin cancer physicians. The conference is open to primary care physicians, dermatologists, otolaryngologists, radiologists, medical oncologists, radiation oncologists, plastic surgeons, general surgeons, pathologists, hospitalists, physician assistants and nurses.

For more information on the Miami Cancer Institute Inaugural Skin Cancer Conference, visit here.

About Miami Cancer Institute

Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK. For more information, please visit https://cancer.baptisthealth.net/miami-cancer-institute.

Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches.